Extend your brand profile by curating daily news.

ParaZero Technologies Appoints Bat-Sheva Noy as Vice President of Global Sales

By Advos

TL;DR

ParaZero Technologies appoints Bat-Sheva Noy as VP of Global Sales, leveraging her 20+ years at Pfizer to expand market access in the growing drone safety sector.

ParaZero Technologies enhances its global sales strategy by appointing Bat-Sheva Noy, whose experience in strategic planning and cross-functional leadership supports commercial expansion.

This appointment strengthens ParaZero's mission to enhance aerial safety worldwide through smart autonomous solutions, making drone operations safer for communities.

A former Pfizer business lead now drives global sales for ParaZero, bringing rare disease strategy experience to the aerospace and drone safety industry.

Found this article helpful?

Share it with your network and spread the knowledge!

ParaZero Technologies Appoints Bat-Sheva Noy as Vice President of Global Sales

ParaZero Technologies Ltd. (NASDAQ: PRZO), an aerospace defense company focused on smart autonomous solutions for the global manned and unmanned aerial systems industry, has appointed Bat-Sheva Noy as its new Vice President of Global Sales. The appointment signals the company's strategic push to strengthen its commercial operations in the rapidly expanding drone safety and aerospace market.

Noy brings more than 20 years of commercial and leadership experience to ParaZero, including her most recent role as Business Unit Lead for Rare Diseases at Pfizer Israel from 2020 to 2025. During her tenure at Pfizer, she was responsible for strategy development, team leadership, and overall business performance management. ParaZero stated that her background in strategic planning, market access, and cross-functional leadership will be instrumental in supporting the company's efforts to expand its global commercial presence.

The appointment comes at a critical time for the drone industry, which is experiencing significant growth across commercial, industrial, and governmental sectors. ParaZero's product portfolio includes SafeAir, an autonomous parachute recovery system designed for aerial safety and regulatory compliance; DefendAir, a counter-UAS net-launching platform for protection against hostile drones; and DropAir, a precision aerial delivery system. These technologies address increasing concerns about drone safety, security, and operational efficiency in various environments.

Noy's pharmaceutical industry experience represents an unconventional but potentially valuable perspective for the aerospace defense sector. Her background in navigating complex regulatory environments, developing market access strategies, and leading cross-functional teams could provide ParaZero with competitive advantages as the company seeks to expand its international footprint. The company's mission to redefine aerial operations with intelligent, mission-ready systems that enhance safety, scalability, and security aligns with growing global demand for advanced drone technologies.

Investors can access the latest news and updates relating to PRZO through the company's newsroom at https://ibn.fm/PRZO. The full press release announcing Noy's appointment is available at https://ibn.fm/zU9Pa. This leadership change reflects ParaZero's commitment to strengthening its commercial capabilities as the drone industry continues to evolve and expand into new applications and markets worldwide.

blockchain registration record for this content
Advos

Advos

@advos